Novartis AG (NVS)
144.23
-1.24
(-0.85%)
USD |
NYSE |
Apr 27, 16:00
143.90
-0.33
(-0.23%)
After-Hours: 17:08
Novartis Market Cap : 275.21B for April 27, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Roche Holding AG | 326.30B |
| Amgen, Inc. | 183.36B |
| AstraZeneca PLC | 290.55B |
| Biogen, Inc. | 26.50B |
| Gilead Sciences, Inc. | 158.57B |
Market Cap Related Metrics
| PE Ratio | 20.07 |
| PS Ratio | 5.145 |
| PEG Ratio | 0.8901 |
| Price to Book Value | 5.966 |
| Price to Free Cash Flow | 18.37 |
| Price | 144.23 |
| Earnings Yield | 4.98% |
| PEGY Ratio | 0.7778 |
| Operating PE Ratio | 16.51 |
| Normalized PE Ratio | 19.09 |